Skip to main content

Waverley Pharma Inc(WAVE-X)
TSX Venture

Today's Change
Delayed Last Update

Waverley Pharma Inc

1250 Waverley Street
Suite 4
Winnipeg MB R3T 6C6 CAN
P: 204-928-7907
F: 204-453-1370
https://www.waverleypharma.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics that focuses on oncology. The company products pipeline includes Bortezomib, Pemetrexed, Capecitabine, and Temozolomide, among others.

    Key Executives

    NameTitle
    Larry ThiessenCEO/Director/President
    Haaris UddinCFO

    More from The Globe

    Wednesday’s analyst upgrades and downgrades
    An office building for Goeasy Ltd, a personal lender for subprime borrowers, in Mississauga, Ontario, on March 10, 2026.
    Bullish on Archer-Daniels-Midland Co.
    Monica Rizk
    Constellation ‘well-positioned’ to tackle AI disruption in software industry, company president says
    In this photo illustration, a mobile phone with the logo of Canadian company Constellation Software Inc. is seen in front of business website.
    number cruncher
    Eight telecom stocks to watch during volatile times
    For Number Cruncher column in Globe Investor/ROB only.
    The most oversold and overbought stocks on the TSX
    The TMX Market Centre is shown in Toronto, Wednesday, Sept. 11, 2024.
    Analysts’ forecast returns, recommendations and yields for all stocks in the S&P/TSX SmallCap Index
    The S&P TSX composite index screen at the TMX Market Centre in Toronto is photographed on Friday, November 11, 2022.
    Small caps to watch: Aecon, Maple Leaf Foods, Tecsys and more
    Packages of Maple Leaf Foods chicken breasts are shown on a shelf at a grocery store in Oakville, Ont., Friday, Jan.6, 2023.
    Thursday’s analyst upgrades and downgrades
    A pumpjack operates at the Vermilion Energy site in Trigueres, France, June 14, 2024.

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.